menu
White Paper
Wendell Jones, Ph.D. | March 11, 2020

RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers

Article published in the journal Cancers
Our bioinformatics team contributed to this article, published in the journal Cancers. Download article to learn about RNA-based immune signatures that could serve as potential markers across tumor types as they are tested for association with outcome in high-grade serous ovarian cancer (HGSOC) and other female cancers. 

Related Services:
Supplementary Materials for RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers

Article published in the journal Cancers

Immune Landscape Signatures for Characterization of Tumor Microenvironment and Response to Therapy

Gene expression and analysis for detection of 15 Immune Landscape Signatures

A Pan-cancer View of Immune Cell Activity, Immune Checkpoints, and Tumor Mutational Burden

Aspects of immune cell activity and their pro and anti-tumor characteristics

Long-Term Disease-Free Survival in High Grade Serous Ovarian Cancer (HGSOC) is Dependent on Immune Microenvironment Characteristics of Primary Tumor

Application of RNA-based immune signatures in predicting disease-free survival

Read More